nintedanib esilate

Italy

Drugs containing this active substance

  • NINTEDANIB ACCORD PHARMA

    It is used in combination with docetaxel to treat a specific type of lung cancer (adenocarcinoma non-small cell lung cancer) in adult patients who have already received another treatment and whose tumor has recurred.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • NINTEDANIB AUROBINDO

    It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, fibrosing interstitial lung diseases in children and adolescents (6-17 years), and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults and young people.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

    Manufacturer: Eugia Pharma (Malta) Limited

  • NINTEDANIB CIPLA

    It is used for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic progressive fibrosing interstitial lung diseases (ILD) in adults, progressive fibrosing interstitial lung diseases in children and adolescents (6-17 years), and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, children, and adolescents aged 6 years and older. The drug helps to reduce the appearance of new scarring and the stiffening of the lungs.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

    Manufacturer: CIPLA EUROPE NV

  • NINTEDANIB INTAS

    This medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and interstitial lung disease associated with systemic sclerosis (SSc-ILD). It helps to reduce the further appearance of scarring and the stiffening of the lungs.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

    Manufacturer: INTAS THIRD PARTY SALES 2005, S.L.

  • NIPFILAN

    This medicinal product is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, fibrosing interstitial lung diseases in children and adolescents (from 6 years of age and older), and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, adolescents, and children from 6 years of age and older. It helps to reduce the appearance of further scarring and lung stiffness.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

    Manufacturer: G.L. PHARMA GMBH

  • OFEV

    Ofev is used for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic progressive fibrosing interstitial lung diseases (ILD) in adults, and progressive fibrosing interstitial lung diseases (ILD) in children and adolescents (between 6 and 17 years of age). It is also indicated for systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, children, and adolescents.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

    Manufacturer: BOEHRINGER INGELHEIM INTERNATIONAL GMBH

  • VARGATEF

    Vargatef is used in combination with docetaxel to treat a specific type of lung cancer (adenocarcinoma non-small cell lung cancer) in adult patients who have already received another treatment and whose tumor has recurred.

    Form: capsules, soft gelatin

    Active substance Dosage
    nintedanib esilate -

    ATC: L01EX09

    Manufacturer: BOEHRINGER INGELHEIM INTERNATIONAL GMBH